These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15882931)

  • 1. Acute repetitive transcranial magnetic stimulation reactivates dopaminergic system in lesion rats.
    Funamizu H; Ogiue-Ikeda M; Mukai H; Kawato S; Ueno S
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):77-81. PubMed ID: 15882931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.
    Shaw VE; Keay KA; Ashkan K; Benabid AL; Mitrofanis J
    Parkinsonism Relat Disord; 2010 Jun; 16(5):338-44. PubMed ID: 20227323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in antidepressant-like effect of chronic repetitive transcranial magnetic stimulation in rats.
    Yang Y; Li W; Zhu B; Liu Y; Yang B; Wang H; Wang Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):735-40. PubMed ID: 17291659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.
    Capitelli C; Sereniki A; Lima MM; Reksidler AB; Tufik S; Vital MA
    Eur J Pharmacol; 2008 Oct; 594(1-3):101-8. PubMed ID: 18674531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP.
    Belzunegui S; San Sebastián W; Garrido-Gil P; Izal-Azcárate A; Vázquez-Claverie M; López B; Marcilla I; Lanciego JL; Luquin MR
    Synapse; 2007 Dec; 61(12):1006-12. PubMed ID: 17853434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant.
    Arias-Carrión O; Hernández-López S; Ibañez-Sandoval O; Bargas J; Hernández-Cruz A; Drucker-Colín R
    J Neurosci Res; 2006 Nov; 84(7):1425-37. PubMed ID: 17006899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
    J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
    Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
    Wang WF; Wu SL; Liou YM; Wang AL; Pawlak CR; Ho YJ
    Behav Neurosci; 2009 Dec; 123(6):1261-70. PubMed ID: 20001109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does melatonin help save dopaminergic cells in MPTP-treated mice?
    Ma J; Shaw VE; Mitrofanis J
    Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
    Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O
    Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
    Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repetitive transcranial magnetic stimulation on adenosine triphosphate content and microtubule associated protein-2 expression after cerebral ischemia-reperfusion injury in rat brain.
    Feng HL; Yan L; Cui LY
    Chin Med J (Engl); 2008 Jul; 121(14):1307-12. PubMed ID: 18713553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.